Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
50000 participants
OBSERVATIONAL
2022-09-01
2030-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
How Many Patients Suffering Major Trauma Would be Eligible for a Pre-hospital Transfusion
NCT06494293
TRansfusion Strategies in Acute Brain INjured Patients
NCT02968654
Common Causes of Blood Transfusion Events in a University Hospital: Analysis of Incident Reports
NCT01812499
Epidemiology of Severe Peroperative Bleeding During Scheduled Surgery
NCT02311309
Survival After Blood Transfusion in the French Administrative Regions of Burgundy and Franche-Comté
NCT02852993
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients will be informed at the time of the anaesthesia consultation about the inclusion in the registry.
The data will be collected from the patients' files by the investigators of the centre without modifying their management.
The data collection period will not exceed the period of acute management.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transfused patients
patients who received an hemostatic product
Transfusion
Transfusion of an hemostatic product
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transfusion
Transfusion of an hemostatic product
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Erasme University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Université libre de Bruxelles
Anderlecht, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STAR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.